Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)


Monday 17 February, 2020

Benchmark Hlgs PLC

Result of General Meeting and Total Voting Rights

RNS Number : 2602D
Benchmark Holdings PLC
17 February 2020

Benchmark Holdings plc

("Benchmark" or the "Company")


Result of General Meeting


Total Voting Rights


Benchmark Holdings plc (AIM: BMK), the aquaculture health, nutrition and genetics business, announces that, at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Accordingly, the Company has raised gross proceeds of £43.0 million from the Fundraise and has issued and allotted 107,440,766 New Shares, conditional only on Admission becoming effective. Admission of the New Shares is expected at or around 8.00 a.m. on 19 February 2020.


Following Admission, the Company's issued ordinary share capital will comprise 667,359,046 Ordinary Shares, of which none are held in treasury. The above figure of 667,359,046 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.


A summary of the votes received will be made available on the Group's website at Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 30 January 2020.




Benchmark Holdings PLC

Septima Maguire, CFO


+44 (0)20 3696 0630

Ivonne Cantu, Investor Relations






Numis Securities



Freddie Barnfield, Duncan Monteith (Nominated Adviser)


+44 (0)20 7260 1000

James Black (Corporate Broking)






MHP Communications



Katie Hunt / Reg Hoare / Alistair de Kare-Silver


+44 (0)20 3128 8742



About Benchmark Holdings PLC


Benchmark's mission is to enable food producers to improve their sustainability and profitability.


We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.


Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t